| Identification | Back Directory | [Name]
2-Propenamide, 3-[6-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl][1,2,4]triazolo[1,5-a]pyridin-5-yl]-, (2E)- | [CAS]
2169299-67-4 | [Synonyms]
GFH018
2-Propenamide, 3-[6-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl][1,2,4]triazolo[1,5-a]pyridin-5-yl]-, (2E)- | [Molecular Formula]
C21H19N7O | [MOL File]
2169299-67-4.mol | [Molecular Weight]
385.42 |
| Hazard Information | Back Directory | [Uses]
TGF-βRI inhibitor 1 (compoimd i) is a TGF-βRI inhibitor. TGF-βRI inhibitor 1 can be used for cancer research[1]. | [References]
[1] Wu, et al. Crystal form and salt form of TGF- β RI inhibitor and preparation method thereof. Patent, CN111479809A. |
|
|